Annual report
6823.TEDINET S100W50Z
Period2024-04-01 → 2025-03-31
Filed2025-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥27.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥25.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥23.9bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥22.6bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥20.5bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥4.0bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥3.5bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥4.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.6bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.0bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.2bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.3bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.9bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.5bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.9bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.8bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.2bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.6bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.9bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥2.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥39.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥37.1bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥34.6bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥33.2bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥30.7bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.7bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.9bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥31.4bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥29.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥26.6bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥25.3bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥23.7bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.2bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.2bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥5.8bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥3.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.8bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.2bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥952m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥749m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥566m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥577m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥542m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥566m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥232.19 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥215.51 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥146.33 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥181.41 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥133.27 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,551.75 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,372.88 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,163.3 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,057.4 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,931.15 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 80.3% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.7% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.0% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.3% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.3% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 9.4% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.5% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.1% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,009 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 1,026 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 998 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 954 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 932 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥22.9bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥21.0bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥18.5bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥18.2bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥3.5bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥2.8bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥4.4bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.2bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.6bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.9bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.0bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.2bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥4.1bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥3.3bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥3.4bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥1.6bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.1bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.4bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥37.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥34.3bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥30.7bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥29.9bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥27.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥7.6bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥7.4bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥29.5bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥26.9bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥24.0bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥23.0bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥21.5bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.3bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.7bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥269.12 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥278.19 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥129.53 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.29 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.15 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥70 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥55 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥43 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,390.82 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,188.6 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,954.68 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,872.33 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,750.31 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 79.6% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.5% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.4% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.1% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.0% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 11.8% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.4% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.5% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 12,336,700 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,327,900 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,319,100 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,309,100 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,303,400 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 504 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 508 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 495 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 504 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 502 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 60
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥142m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥88m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥9.1bn |
| Environmental Equipmentreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥296m |
| Environmental Equipmentreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥246m |
| Environmental Equipmentreportable segment | employees | at 2025-03-31 | 192 pure |
| Environmental Equipmentreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥5.8bn |
| Environmental Equipmentreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥5.8bn |
| Environmental Equipmentreportable segment | segment assets | at 2025-03-31 | ¥7.1bn |
| Environmental Equipmentreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥164m |
| Medical Equipmentreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥612m |
| Medical Equipmentreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥456m |
| Medical Equipmentreportable segment | employees | at 2025-03-31 | 548 pure |
| Medical Equipmentreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥12.5bn |
| Medical Equipmentreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥12.5bn |
| Medical Equipmentreportable segment | segment assets | at 2025-03-31 | ¥11.5bn |
| Medical Equipmentreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Particle Countersreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥565m |
| Particle Countersreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥384m |
| Particle Countersreportable segment | employees | at 2025-03-31 | 159 pure |
| Particle Countersreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥9.5bn |
| Particle Countersreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥9.5bn |
| Particle Countersreportable segment | segment assets | at 2025-03-31 | ¥11.5bn |
| Particle Countersreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥2.8bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥1.5bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥27.9bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥27.9bn |
| —segment total | segment assets | at 2025-03-31 | ¥30.0bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥4.0bn |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥238m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥63m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥8.0bn |
| Environmental Equipmentreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥545m |
| Environmental Equipmentreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥186m |
| Environmental Equipmentreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥5.4bn |
| Environmental Equipmentreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥5.4bn |
| Environmental Equipmentreportable segment | segment assets | at 2024-03-31 | ¥7.5bn |
| Environmental Equipmentreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥104m |
| Medical Equipmentreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Medical Equipmentreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥346m |
| Medical Equipmentreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥12.7bn |
| Medical Equipmentreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥12.7bn |
| Medical Equipmentreportable segment | segment assets | at 2024-03-31 | ¥12.4bn |
| Medical Equipmentreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥1.3bn |
| Particle Countersreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥804m |
| Particle Countersreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥242m |
| Particle Countersreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥7.6bn |
| Particle Countersreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥7.6bn |
| Particle Countersreportable segment | segment assets | at 2024-03-31 | ¥9.3bn |
| Particle Countersreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥2.1bn |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥2.5bn |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥774m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥25.7bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥25.7bn |
| —segment total | segment assets | at 2024-03-31 | ¥29.1bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥3.5bn |
| Environmental Equipmentreportable segment | employees | at 2025-03-31 | 140 pure |
| Medical Equipmentreportable segment | employees | at 2025-03-31 | 200 pure |
| Particle Countersreportable segment | employees | at 2025-03-31 | 109 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,571
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 123094 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 10000 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 12336700 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 123094 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 17300 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 17300 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0014 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 17300 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 17300 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0014 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 344000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 28 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row2Member | 517000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row2Member | 42 | |
| Number of male directors and other officers | FilingDateInstant | 8 | |
| Number of female directors and other officers | FilingDateInstant | 3 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.273 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01842-000KatoKokiMember | 15000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01842-000IwahashiKiyokatsuMember | 32000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01842-000ShimizuKenichiMember | 39000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01842-000ShinozakiToshiyukiMember | 4000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01842-000HamadaKikukoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01842-000UedaMariMember | 3000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01842-000TakahashiKazunobuMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01842-000EjimaShinyaMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01842-000NakanowatariMakotoMember | 2000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01842-000SakumaYoshihiroMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01842-000TeramachiTokoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 99000 | |
| Audit fees reporting company | Prior1YearDuration | 38000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 37500000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Audit fees total | Prior1YearDuration | 38000000 | JPY |
| Non audit fees total | Prior1YearDuration | － | JPY |
| Audit fees total | CurrentYearDuration | 37500000 | JPY |
| Non audit fees total | CurrentYearDuration | － | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 132385000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 64920000 | JPY |
| Monetary remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 44220000 | JPY |
| Non monetary remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 23245000 | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 4 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 14400000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 14400000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |